| Esophageal Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived108 of 108show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 59 trials (28 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 56 trials (21 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 47 trials (19 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 39 trials (13 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 35 trials (15 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 30 trials (18 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 30 trials (17 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 29 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 27 trials (17 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 24 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 21 trials (9 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 18 trials (13 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 18 trials (9 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxel Liposome 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-6 Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall_molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumab/Trastuzumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Raltitrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zongertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |